These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14685078)

  • 1. Efficacy and safety measurements of proton pump inhibitors in infants and children.
    James LP
    J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S46-51. PubMed ID: 14685078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-pump inhibitors are the treatment of choice in acid-related disease.
    Brunner G
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S9-13. PubMed ID: 8930574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M
    Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of famotidine in paediatric patients.
    James LP; Kearns GL
    Clin Pharmacokinet; 1996 Aug; 31(2):103-10. PubMed ID: 8853932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of proton pump inhibitors in children: a comprehensive review.
    Gibbons TE; Gold BD
    Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety data required for proton-pump inhibitor use in children.
    Scaillon M; Cadranel S
    J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):113-8. PubMed ID: 12187284
    [No Abstract]   [Full Text] [Related]  

  • 11. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
    Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
    Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists.
    Lazzaroni M; Bianchi Porro G
    Drugs Aging; 1996 Oct; 9(4):251-61. PubMed ID: 8894523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole.
    Uesugi T; Mikawa K; Nishina K; Morikawa O; Takao Y; Obara H
    Anesth Analg; 2002 Jul; 95(1):144-7, table of contents. PubMed ID: 12088958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy for gastroesophageal reflux disease in 2007.
    Katz PO
    Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroduodenal Ulceration in Small Animals: Part 2. Proton Pump Inhibitors and Histamine-2 Receptor Antagonists.
    Daure E; Ross L; Webster CR
    J Am Anim Hosp Assoc; 2017; 53(1):11-23. PubMed ID: 27841679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics.
    Kearns GL; Winter HS
    J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S52-9. PubMed ID: 14685079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heartburn, gastroesophageal reflux (GER), and gastroesophageal reflux disease (GERD).
    J Pract Nurs; 2008; 58(3):21-3. PubMed ID: 19180847
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of histamine-2 receptor antagonists.
    van der Pol R; Langendam M; Benninga M; van Wijk M; Tabbers M
    JAMA Pediatr; 2014 Oct; 168(10):947-54. PubMed ID: 25133940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
    Vakhrushev IaM; Muravtseva OV
    Eksp Klin Gastroenterol; 2002; (2):29-31, 101. PubMed ID: 12046381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.